GlaxoSmithKline Plc released its unaudited financial results for the third quarter of the year ended 30th of September, 2021.
- Revenue during the period was N6.59 billion. (+9.55% YoY)
- Cost of sales stood at N4.99 billion. (+11.10% YoY)
- Selling and Distribution costs for the period was N1.15 billion. (+20.21% YoY)
- Administrative expenses of N559 million was recorded.
- Profit before tax was N92.64 million (+49.88%). Total assets during the period stood at N23.49 billion. (+1.23 bn YoY)
- Profit after tax was N62.79 million. (+49.41 YoY)
- Earnings per share of 5 kobo Vs 4 kobo YoY.
See link to results
